Principal Financial Group
CRMD icon

Principal Financial Group’s CorMedix CRMD Stock Holding History

Principal Financial Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Buy
179,537
+52,804
+42% +$390K ﹤0.01% 1897
2025
Q4 		$1.47M Buy
126,733
+40,296
+47% +$445K ﹤0.01% 1892
2025
Q3 		$1.01M Buy
+86,437
New +$1.05M ﹤0.01% 1925
2024
Q3 		– Sell
-10,229
Closed -$44.3K – 2267
2024
Q2 		$44.3K Buy
+10,229
New +$52K ﹤0.01% 2296
2020
Q2 		– Sell
-19,724
Closed -$71K – 2328
2020
Q1 		$71K Buy
19,724
+67
+0.3% +$378 ﹤0.01% 2141
2019
Q4 		$143K Sell
19,657
-6,938
-26% -$42.4K ﹤0.01% 2172
2019
Q3 		$170K Buy
26,595
+188
+0.7% +$1.58K ﹤0.01% 2155
2019
Q2 		$237K Buy
+26,407
New +$207K ﹤0.01% 2114

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Principal Financial Group's CRMD Position: Q1 2026 in Review

Principal Financial Group increased its CorMedix (CRMD) stake by 42% in Q1 2026, buying an estimated $390K and bringing the position to 179,537 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Principal Financial Group first reported a position in CRMD in Q2 2019 and has held it in 8 quarters since. The position peaked at $1.47M in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Principal Financial Group held 179,537 shares of CorMedix worth $1.22M as of Q1 2026.
  • Principal Financial Group bought 52,804 CorMedix shares in Q1 2026, an estimated $390K.
  • CorMedix made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #1897 holding.
  • Principal Financial Group first reported a position in CorMedix in Q2 2019 and has held it in 8 quarters since.
  • Principal Financial Group's CorMedix position peaked at $1.47M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.